Inflammation in chronic wounds

International Journal of Molecular Sciences

Volumn 17, Issue 12, 2016, Pages

  Zhao, Ruilong ^a   Liang, Helena ^a   Clarke, Elizabeth ^a   Jackson, Christopher ^a   Xue, Meilang ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Ageing; Arterial ulcer; Bacterial colonisation; Chronic wound; Diabetic ulcer; Hypoxia; Inflammation; Ischaemia reperfusion; Pressure ulcer; Venous ulcer

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANTIBIOTIC AGENT; CD16 ANTIGEN; FIBROBLAST GROWTH FACTOR 2; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; NEUTROPHIL COLLAGENASE; NEUTROPHIL COLLAGENASE 8; NITRIC OXIDE; PLATELET DERIVED GROWTH FACTOR; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

AGING; BACTERIAL COLONIZATION; CELL PROLIFERATION; CHRONIC WOUND; DEBRIDEMENT; DECUBITUS; DIABETIC FOOT; EXTRACELLULAR MATRIX; HEMOSTASIS; HUMAN; HYPOXIA; INFLAMMATION; MOLECULAR PATHOLOGY; PHASE 3 CLINICAL TRIAL (TOPIC); PROTEIN EXPRESSION; REPERFUSION INJURY; REVIEW; SKIN ULCER; WOUND DRESSING; CHRONIC DISEASE; COMPLICATION; PATHOLOGY; PATHOPHYSIOLOGY; SKIN; WOUND HEALING; WOUNDS AND INJURIES;

CHRONIC DISEASE; HUMANS; INFLAMMATION; SKIN; WOUND HEALING; WOUNDS AND INJURIES;

EID: 85006127187     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17122085     Document Type: Review

References (94)

1. Li, J.; Chen, J.; Kirsner, R. Pathophysiology of acute wound healing. Clin. Dermatol. 2007, 25, 9–18.
2. Reinke, J.M.; Sorg, H. Wound repair and regeneration. Eur. Surg. Res. 2012, 49, 35–43.
3. Nunan, R.; Harding, K.G.; Martin, P. Clinical challenges of chronic wounds: Searching for an optimal animal model to recapitulate their complexity. Dis. Model. Mech. 2014, 7, 1205–1213.
4. Fonder, M.A.; Lazarus, G.S.; Cowan, D.A.; Aronson-Cook, B.; Kohli, A.R.; Mamelak, A.J. Treating the chronic wound: A practical approach to the care of nonhealing wounds and wound care dressings. J. Am. Acad. Dermatol. 2008, 58, 185–206.
5. Diegelmann, R.F.; Evans, M.C. Wound healing: An overview of acute, fibrotic and delayed healing. Front. Biosci. 2004, 9, 283–289.
6. Goldman, R. Growth factors and chronic wound healing: Past, present, and future. Adv. Skin Wound Care 2004, 17, 24–35.
7. Sen, C.K.; Gordillo, G.M.; Roy, S.; Kirsner, R.; Lambert, L.; Hunt, T.K.; Gottrup, F.; Gurtner, G.C.; Longaker, M.T. Human skin wounds: A major and snowballing threat to public health and the economy. Wound Repair Regen. 2009, 17, 763–771.
8. Hurd, T. Understanding the financial benefits of optimising wellbeing in patients living with a wound. Wounds Int. 2013, 4, 13–17.
9. Driscoll, P. Wound prevalence and wound management, 2012–2020. 2013. Available online: http://blog.mediligence.com/2013/01/29/wound-prevalence-and-wound-management-2012-2020/ (accessed on 14 September 2015).
10. Mustoe, T. Understanding chronic wounds: A unifying hypothesis on their pathogenesis and implications for therapy. Am. J. Surg. 2004, 187, S65–S70.
11. Rudolph, R. Location of the force of wound contraction. Surg. Gynecol. Obstet. 1979, 148, 547–551.
12. McGrath, M.H.; Simon, R.H. Wound geometry and the kinetics of wound contraction. Plast Reconstr. Surg. 1983, 72, 66–73.
13. Volk, S.W.; Bohling, M.W. Comparative wound healing—Are the small animal veterinarian‘s clinical patients an improved translational model for human wound healing research? Wound Repair Regen. 2013, 21, 372–381.
14. Eming, S.A.; Martin, P.; Tomic-Canic, M. Wound repair and regeneration: Mechanisms, signaling, and translation. Sci. Transl. Med. 2014, 6.
15. Demidova-Rice, T.N.; Hamblin, M.R.; Herman, I.M. Acute and impaired wound healing: Pathophysiology and current methods for drug delivery, part 1: Normal and chronic wounds: Biology, causes, and approaches to care. Adv. Skin Wound Care 2012, 25, 304–314.
16. Word, R. Medical and surgical therapy for advanced chronic venous insufficiency. Surg. Clin. North Am. 2010, 90, 1195–1214.
17. Trent, J.T.; Falabella, A.; Eaglstein, W.H.; Kirsner, R.S. Venous ulcers: Pathophysiology and treatment options. Ostomy Wound Manage. 2005, 51, 38–54.
18. Bonham, P.A. Assessment and management of patients with venous, arterial, and diabetic/neuropathic lower extremity wounds. AACN Clin. Issues 2003, 14, 442–456.
19. Fowkes, F.G.; Rudan, D.; Rudan, I.; Aboyans, V.; Denenberg, J.O.; McDermott, M.M.; Norman, P.E.; Sampson, U.K.; Williams, L.J.; Mensah, G.A.; Criqui, M.H. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: A systematic review and analysis. Lancet 2013, 382, 1329–1340.
20. Grey, J.E.; Harding, K.G.; Enoch, S. Venous and arterial leg ulcers. BMJ 2006, 332, 347–350.
21. Bansal, C.; Scott, R.; Stewart, D.; Cockerell, C.J. Decubitus ulcers: A review of the literature. Int. J. Dermatol. 2005, 44, 805–810.
22. Garwood, C.S.; Steinberg, J.S.; Kim, P.J. Bioengineered alternative tissues in diabetic wound healing. Clin. Podiatr. Med. Surg. 2015, 32, 121–133.
23. Baltzis, D.; Eleftheriadou, I.; Veves, A. Pathogenesis and treatment of impaired wound healing in diabetes mellitus: New insights. Adv. Ther. 2014, 31, 817–836.
24. Falanga, V. Wound healing and its impairment in the diabetic foot. Lancet 2005, 366, 1736–1743.
25. Blakytny, R.; Jude, E. The molecular biology of chronic wounds and delayed healing in diabetes. Diabet. Med. 2006, 23, 594–608.
26. Peppa, M.; Stavroulakis, P.; Raptis, S.A. Advanced glycoxidation products and impaired diabetic wound healing. Wound Repair Regen. 2009, 17, 461–472.
27. Gary Sibbald, R.; Woo, K.Y. The biology of chronic foot ulcers in persons with diabetes. Diabetes Metab. Res. Rev. 2008, 24, S25–S30.
28. Berlanga-Acosta, J.; Schultz, G.S.; Lopez-Mola, E.; Guillen-Nieto, G.; Garcia-Siverio, M.; Herrera-Martinez, L. Glucose toxic effects on granulation tissue productive cells: The diabetics‘impaired healing. Biomed. Res. Int. 2013, 2013, 256043.
29. Nagaraja, S.; Wallqvist, A.; Reifman, J.; Mitrophanov, A.Y. Computational approach to characterize causative factors and molecular indicators of chronic wound inflammation. J. Immunol. 2014, 192, 1824–1834.
30. Noli, C.; Miolo, A. The mast cell in wound healing. Vet. Dermatol. 2001, 12, 303–313.
31. Xue, M.; Jackson, C.J. Extracellular matrix reorganization during wound healing and its impact on abnormal scarring. Adv. Wound Care 2013, 4, 119–136.
32. Werner, S.; Grose, R. Regulation of wound healing by growth factors and cytokines. Physiol. Rev. 2003, 83, 835–870.
33. Martin, P. Wound healing—Aiming for perfect skin regeneration. Science 1997, 276, 75–81.
34. Barker, T.H. The role of ECM proteins and protein fragments in guiding cell behavior in regenerative medicine. Biomaterials 2011, 32, 4211–4214.
35. Eckes, B.; Nischt, R.; Krieg, T. Cell-matrix interactions in dermal repair and scarring. Fibrogenesis Tissue Repair 2010, 3, 4.
36. Darby, I.; Skalli, O.; Gabbiani, G. α-Smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab. Invest. 1990, 63, 21–29.
37. Simon, P.E.; outran, H.A.; Romo T., III; Pafford, W.; Pearson, J.M.; Yalamanchili, H.; Zoumalan, R.A. Skin Wound Healing. 2014. Available online: http://emedicine.medscape.com/article/884594-overview (accessed on 24 December 2014).
38. Desmouliere, A.; Redard, M.; Darby, I.; Gabbiani, G. Apoptosis mediates the decrease in cellularity during the transition between granulation-tissue and scar. Am. J. Pathol. 1995, 146, 56–66.
39. Ferguson, M.W.; O‘Kane, S. Scar-free healing: From embryonic mechanisms to adult therapeutic intervention. Philos. Trans. R Soc. Lond. B Biol. Sci. 2004, 359, 839–850.
40. Szpaderska, A.M.; DiPietro, L.A. Inflammation in surgical wound healing: Friend or foe? Surgery 2005, 137, 571–573.
41. Gurtner, G.C.; Werner, S.; Barrandon, Y.; Longaker, M.T. Wound repair and regeneration. Nature 2008, 453, 314–321.
42. You, H.-J.; Han, S.-K. Cell therapy for wound healing. J. Korean Med. Sci. 2014, 29, 311–319.
43. Brockes, J.P.; Kumar, A.; Velloso, C.P. Regeneration as an evolutionary variable. J Anat. 2001, 199, 3–11.
44. Colwell, A.S.; Krummel, T.M.; Longaker, M.T.; Lorenz, H.P. An in vivo mouse excisional wound model of scarless healing. Plast. Reconstr. Surg. 2006, 117, 2292–2296.
45. Rowlatt, U. Intrauterine wound healing in a 20 week human fetus. Virchows Arch. A Pathol. Anat. Histol. 1979, 381, 353–361.
46. Adzick, N.S.; Lorenz, H.P. Cells, matrix, growth factors, and the surgeon. The biology of scarless fetal wound repair. Ann. Surg. 1994, 220, 10–18.
47. Stojadinovic, A.; Carlson, J.W.; Schultz, G.S.; Davis, T.A.; Elster, E.A. Topical advances in wound care. Gynecol. Oncol. 2008, 111, S70–S80.
48. Schultz, G.S.; Mast, B.A. Molecular analysis of the environment of healing and chronic wounds: Cytokines, proteases, and growth factors. Wounds Compend. Clin. Res. Pract. 1998, 10, 1f–9f.
49. Eming, S.A.; Krieg, T.; Davidson, J.M. Inflammation in wound repair: Molecular and cellular mechanisms. J. Invest. Dermatol. 2007, 127, 514–525.
50. Van der Veer, W.M.; Bloemen, M.C.; Ulrich, M.M.; Molema, G.; van Zuijlen, P.P.; Middelkoop, E.; Niessen, F.B. Potential cellular and molecular causes of hypertrophic scar formation. Burns 2009, 35, 15–29.
51. Mast, B.A.; Schultz, G.S. Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Repair Regen. 1996, 4, 411–420.
52. Schreml, S.; Szeimies, R.M.; Prantl, L.; Karrer, S.; Landthaler, M.; Babilas, P. Oxygen in acute and chronic wound healing. Br. J. Dermatol. 2010, 163, 257–268.
53. Gosain, A.; DiPietro, L.A. Aging and wound healing. World J. Surg. 2004, 28, 321–326.
54. Engeland, C.G.; Bosch, J.A.; Cacioppo, J.T.; Marucha, P.T. Mucosal wound healing: The roles of age and sex. Arch. Surg. 2006, 141, 1193–1197.
55. Ashcroft, G.S.; Mills, S.J.; Ashworth, J.J. Ageing and wound healing. Biogerontology 2002, 3, 337–345.
56. Ashcroft, G.S.; Greenwell-Wild, T.; Horan, M.A.; Wahl, S.M.; Ferguson, M.W. Topical estrogen accelerates cutaneous wound healing in aged humans associated with an altered inflammatory response. Am. J. Pathol. 1999, 155, 1137–1146.
57. Ashcroft, G.S.; Horan, M.A.; Ferguson, M.W. The effects of ageing on cutaneous wound healing in mammals. J. Anat. 1995, 187, 1–26.
58. Ashcroft, G.S.; Horan, M.A.; Ferguson, M.W.J. Aging is associated with reduced deposition of specific extracellular matrix components, upregulation of angiogenesis, and an altered inflammatory response in a murine incisional wound healing model. J. Invest. Dermatol. 1997, 108, 430–437.
59. Gouin, J.P.; Hantsoo, L.; Kiecolt-Glaser, J.K. Immune Dysregulation and chronic stress among older adults: A review. Neuroimmunomodulation 2008, 15, 251–259.
60. Toledo-Pereyra, L.H.; Lopez-Neblina, F.; Toledo, A.H. Reactive oxygen species and molecular biology of ischemia/reperfusion. Ann. Transplant. 2004, 9, 81–83.
61. Peschen, M.; Lahaye, T.; Hennig, B.; Weyl, A.; Simon, J.C.; Vanscheidt, W. Expression of the adhesion molecules ICAM-1, VCAM-1, LFA-1 and VLA-4 in the skin is modulated in progressing stages of chronic venous insufficiency. Acta Derm. Venereol. 1999, 79, 27–32.
62. Soneja, A.; Drews, M.; Malinski, T. Role of nitric oxide, nitroxidative and oxidative stress in wound healing. Pharmacol. Rep. 2005, 57, 108–119.
63. Connelly, L.; Palacios-Callender, M.; Ameixa, C.; Moncada, S.; Hobbs, A.J. Biphasic regulation of NF-κB activity underlies the pro- and anti-inflammatory actions of nitric oxide. J. Immunol. 2001, 166, 3873–3881.
64. Anaya-Prado, R.; Toledo-Pereyra, L.H.; Lentsch, A.B.; Ward, P.A. Ischemia/reperfusion injury. J. Surg. Res. 2002, 105, 248–258.
65. Mudge, E.J. Recent accomplishments in wound healing. Int. Wound J. 2015, 12, 4–9.
66. James, G.A.; Swogger, E.; Wolcott, R.; Pulcini, E.; Secor, P.; Sestrich, J.; Costerton, J.W.; Stewart, P.S. Biofilms in chronic wounds. Wound Repair Regen. 2008, 16, 37–44.
67. Zhao, G.; Usui, M.L.; Lippman, S.I.; James, G.A.; Stewart, P.S.; Fleckman, P.; Olerud, J.E. Biofilms and inflammation in chronic wounds. Adv. Wound Care 2013, 2, 389–399.
68. Wolcott, R.D.; Rhoads, D.D.; Dowd, S.E. Biofilms and chronic wound inflammation. J. Wound Care 2008, 17, 333–341.
69. Schultz, G.S.; Sibbald, R.G.; Falanga, V.; Ayello, E.A.; Dowsett, C.; Harding, K.; Romanelli, M.; Stacey, M.C.; Teot, L.; Vanscheidt, W. Wound bed preparation: A systematic approach to wound management. Wound Repair Regen. 2003, 11, S1–S28.
70. Hershcovitch, M.D.; Hom, D.B. Update in wound healing in facial plastic surgery. Arch. Facial Plast. Surg. 2012, 14, 387–393.
71. Meier, K.; Nanney, L.B. Emerging new drugs for wound repair. Expert. Opin. Emerg. Drugs 2006, 11, 23–37.
72. Barrientos, S.; Stojadinovic, O.; Golinko, M.S.; Brem, H.; Tomic-Canic, M. Perspective article: Growth factors and cytokines in wound healing. Wound Repair Regen. 2008, 16, 585–601.
73. Rodgers, K.E.; Bolton, L.L.; Verco, S.; di Zerega, G.S. NorLeu-angiotensin (1–7) [DSC127] as a therapy for the healing of diabetic foot ulcers. Adv. Wound Care 2015, 4, 339–345.
74. Sogabe, Y.; Abe, M.; Yokoyama, Y.; Ishikawa, O. Basic fibroblast growth factor stimulates human keratinocyte motility by Rac activation. Wound Repair Regen. 2006, 14, 457–462.
75. Robson, M.C.; Phillips, L.G.; Lawrence, W.T.; Bishop, J.B.; Youngerman, J.S.; Hayward, P.G.; Broemeling, L.D.; Heggers, J.P. The safety and effect of topically applied recombinant basic fibroblast growth factor on the healing of chronic pressure sores. Ann. Surg. 1992, 216, 401–406.
76. Richard, J.L.; Parer-Richard, C.; Daures, J.P.; Clouet, S.; Vannereau, D.; Bringer, J.; Rodier, M.; Jacob, C.; Comte-Bardonnet, M. Effect of topical basic fibroblast growth factor on the healing of chronic diabetic neuropathic ulcer of the foot. A pilot, randomized, double-blind, placebo-controlled study. Diabetes Care 1995, 18, 64–69.
77. Uchi, H.; Igarashi, A.; Urabe, K.; Koga, T.; Nakayama, J.; Kawamori, R.; Tamaki, K.; Hirakata, H.; Ohura, T.; Furue, M. Clinical efficacy of basic fibroblast growth factor (bFGF) for diabetic ulcer. Eur. J. Dermatol. 2009, 19, 461–468.
78. Kusumanto, Y.H.; van Weel, V.; Mulder, N.H.; Smit, A.J.; van den Dungen, J.J.; Hooymans, J.M.; Sluiter, W.J.; Tio, R.A.; Quax, P.H.; Gans, R.O. et al. Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: A double-blind randomized trial. Hum. Gene Ther. 2006, 17, 683–691.
79. Saaristo, A.; Tammela, T.; Farkkila, A.; Karkkainen, M.; Suominen, E.; Yla-Herttuala, S.; Alitalo, K. Vascular endothelial growth factor-C accelerates diabetic wound healing. Am. J. Pathol. 2006, 169, 1080–1087.
80. Genentech Announces Full Year and Fourth Quarter 2007 Results. 2008. Available online: https://www.gene.com/media/press-releases/10967/2008-01-14/genentech-announces-full-year-and-fourth (accessed on 30 November 2016).
81. Dinh, T.; Braunagel, S.; Rosenblum, B.I. Growth factors in wound healing: The present and the future? Clin. Podiatr. Med. Surg. 2015, 32, 109–119.
82. Sorg, H.; Harder, Y.; Krueger, C.; Reimers, K.; Vogt, P.M. The nonhematopoietic effects of erythropoietin in skin regeneration and repair: From basic research to clinical use. Med. Res. Rev. 2013, 33, 637–664.
83. Mosnier, L.O.; Zlokovic, B.V.; Griffin, J.H. The cytoprotective protein C pathway. Blood 2006, 109, 3161–3172.
84. Uchiba, M.; Okajima, K.; Oike, Y.; Ito, Y.; Fukudome, K.; Isobe, H.; Suda, T. Activated protein C induces endothelial cell proliferation by mitogen-activated protein kinase activation in vitro and angiogenesis in vivo. Circ. Res. 2004, 95, 34–41.
85. Jackson, C.J.; Xue, M.; Thompson, P.; Davey, R.A.; Whitmont, K.; Smith, S.; Buisson-Legendre, N.; Sztynda, T.; Furphy, L.J.; Cooper, A. et al. Activated protein C prevents inflammation yet stimulates angiogenesis to promote cutaneous wound healing. Wound Repair Regen. 2005, 13, 284–294.
86. Julovi, S.M.; Xue, M.; Dervish, S.; Sambrook, P.N.; March, L.; Jackson, C.J. Protease activated receptor-2 mediates activated protein C-induced cutaneous wound healing via inhibition of p38. Am. J. Pathol. 2011, 179, 2233–2242.
87. Whitmont, K.; Reid, I.; Tritton, S.; March, L.; Xue, M.; Lee, M.; Fulcher, G.; Sambrook, P.; Slobedman, E.; Cooper, A. et al. Treatment of chronic leg ulcers with topical activated protein C. Arch. Dermatol. 2008, 144, 1479–1483.
88. Wijewardena, A.; Vandervord, E.; Lajevardi, S.S.; Vandervord, J.; Jackson, C.J. Combination of activated protein C and topical negative pressure rapidly regenerates granulation tissue over exposed bone to heal recalcitrant orthopedic wounds. Int. J. Low. Extrem. Wounds 2011, 10, 146–151.
89. Whitmont, K.; McKelvey, K.J.; Fulcher, G.; Reid, I.; March, L.; Xue, M.; Cooper, A.; Jackson, C.J. Treatment of chronic diabetic lower leg ulcers with activated protein C: A randomised placebo-controlled, double-blind pilot clinical trial. Int. Wound J. 2013, 12, 422–427.
90. Whitmont, K.; Fulcher, G.; Reid, I.; Xue, M.; McKelvey, K.; Xie, Y.; Aboud, M.; Ward, C.; Smith, M.M.; Cooper, A. et al. Low circulating protein C levels are associated with lower leg ulcers in patients with diabetes. Biomed. Res. Int. 2013, 2013, 719570.
91. Kapila, S.; Reid, I.; Dixit, S.; Fulcher, G.; March, L.; Jackson, C.; Cooper, A. Use of dermal injection of activated protein C for treatment of large chronic wounds secondary to pyoderma gangrenosum. Clin. Exper. Dermatol. 2014, 39, 785–790.
92. Marti-Carvajal, A.J.; Sola, I.; Lathyris, D.; Cardona, A.F. Human recombinant activated protein C for severe sepsis. Cochrane Database Syst. Rev. 2012, 3, CD004388.
93. Sarangi, P.P.; Lee, H.-W.; Kim, M. Activated protein C action in inflammation. Br. J. Haematol. 2010, 148, 817–833.
94. Mosnier, L.O.; Sinha, R.K.; Burnier, L.; Bouwens, E.A.; Griffin, J.H. Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46. Blood 2012, 120, 5237–5246.